A transcriptional signature of resting mast cells is associated with improved disease outcome in HR+HER2- breast cancer.
Analysis of transcriptional signatures of immune cell infiltration across three public transcriptomic datasets from patients with breast cancer suggests interactions between mast cells and non-malignant components of the breast cancer microenvironment, particularly fibroblasts, may shape disease progression and treatme...